ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Inhibition of Human Uracil DNA Glycosylase Sensitizes a Large Fraction of Colorectal Cancer Cells to 5-Fluorodeoxyuridine and Raltitrexed but Not Fluorouracil

Christenson, Eric S.; Gizzi, Anthony; Cui, Junru; Egleston, Matthew; Seamon, Kyle J.; DePasquale, Michael; Orris, Benjamin; Park, Ben H.; Stivers, James T.*
Molecular Pharmacology2021-6-1DOI: 10.1124/molpharm.120.000191
3阅读
引用收藏
分享

摘要

Previous short-hairpin RNA knockdown studies have established that depletion of human uracil DNA glycosylase (hUNG) sensitizes some cell lines to 5-fluorodeoxyuridine (FdU). Here, we selectively inhibit the catalytic activity of hUNG by lentiviral transduction of uracil DNA glycosylase inhibitor protein into a large panel of cancer cell lines under control of a doxycycline-inducible promoter. This induced inhibition strategy better assesses the therapeutic potential of small-molecule targeting of hUNG. In total, 6 of 11 colorectal lines showed 6- to 70-fold increases in FdU potency upon hUNG inhibition ("responsive"). This hUNG-dependent response was not observed with fluorouracil (FU), indicating that FU does not operate through the same DNA repair mechanism as FdU in vitro. Potency of the thymidylate synthase inhibitor raltitrexed (RTX), which elevates deoxyuridine triphosphate levels, was only incrementally enhanced upon hUNG inhibition (<40%), suggesting that responsiveness is associated with incorporation and persistence of FdU in DNA rather than deoxyuridine. The importance of FU/A and FU/G lesions in the toxicity of FdU is supported by the observation that dT supplementation completely rescued the toxic effects of U/A lesions resulting from RTX, but dT only increased the IC50 for FdU, which forms both FU/A and FU/G mismatches. Contrary to previous reports, cellular responsiveness to hUNG inhibition did not correlate with p53 status or thymine DNA glycosylase expression. A model is suggested in which the persistence of FU/A and FU/G base pairs in the absence of hUNG activity elicits an apoptotic DNA damage response in both responsive and nonresponsive colorectal lines. SIGNIFICANCE STATEMENT The pyrimidine base 5-fluorouracil is a mainstay chemotherapeutic for treatment of advanced colorectal cancer. Here, this study shows that its deoxynucleoside form, 5-fluorodeoxyuridine (FdU), operates by a distinct DNA incorporation mechanism that is strongly potentiated by inhibition of the DNA repair enzyme human uracil DNA glycosylase. The hUNG-dependent mechanism was present in over 50% of colorectal cell lines tested, suggesting that a significant fraction of human cancers may be sensitized to FdU in the presence of a small-molecule hUNG inhibitor.

学科与关键词

关键词
BASE EXCISION5-FLUOROURACILREPAIRMECHANISMTHYMINEACIDGENE
相关
加载中…
  • 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition.
    Sethy Chinmayee; Kundu Chanakya NathBiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2021.被引 61
  • MBD4 frameshift mutation caused by DNA mismatch repair deficiency enhances cytotoxicity by trifluridine, an active antitumor agent of TAS-102, in colorectal cancer cells.
    Suzuki Satoshi; Iwaizumi Moriya; Yamada Hidetaka; Sugiyama Tomohiro; Hamaya Yasushi; Furuta Takahisa; Kanaoka Shigeru; Sugimura Haruhiko; Miyajima Hiroaki; Osawa Satoshi; Carethers John M; Sugimoto KenONCOTARGET, 2018, 9(14): 11477-11488.
  • Knockdown of DNA binding protein A (dbpA) enhances the chemotherapy sensitivity of colorectal cancer via suppressing the Wnt/&beta;-catenin/Chk1 pathway.
    Tong, Cong; Qu, Kai; Wang, Guorong; Liu, Ruiting; Duan, Baojun; Wang, Xiaoqiang; Liu, ChangCELL BIOLOGY INTERNATIONAL, 2020.
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular Pharmacology
发表日期
2021-06-01
卷期
第 99 卷, 第 6 期
页码
412-425
DOI
10.1124/molpharm.120.000191
语言
ENGLISH
期刊收录
NSL
期刊等级
2区
成果收录
SCIE
资助标注
NIGMS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01 GM056834] Funding Source: Medline

作者

  • C

    Christenson, Eric S. (第一作者)

  • G

    Gizzi, Anthony

查看全部 9 位作者收起作者
  • C

    Cui, Junru

  • E

    Egleston, Matthew

  • S

    Seamon, Kyle J.

  • D

    DePasquale, Michael

  • O

    Orris, Benjamin

  • P

    Park, Ben H.

  • S

    Stivers, James T. (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417